New frontiers in transcatheter heart valve technologies
This article was originally published in Clinica
Executive Summary
The first prototype of a transcatheter heart valve prosthesis was developed as far back as 1965 by Dr Hywel Davies. More than 40 years on, the market for these devices, which offer a minimally-invasive alternative for replacing diseased heart valves to conventional surgery, is growing at double-digit rates. In this article, Sarah Zanon, senior clinical project manager of D-Target*, discusses the competitive landscape of the transcatheter aortic valve implant market and also opportunities in the area of transcatheter mitral valve repair